Mantle Cell Lymphoma

>

Latest News

Early MRD Guides Therapy in Mantle Cell Lymphoma
Early MRD Guides Therapy in Mantle Cell Lymphoma

March 22nd 2024

In an interview with Targeted Oncology, Julie Chang, MD, discussed the minimal residual disease-adapted study in patients with previously untreated mantle cell lymphoma and the key findings from the trial.

What Is High-Risk Mantle Cell Lymphoma, and How Should We Treat It?
What Is High-Risk Mantle Cell Lymphoma, and How Should We Treat It?

February 26th 2024

Liso-cel Appears Effective in High-Risk Patients With MCL
Liso-cel Appears Effective in High-Risk Patients With MCL

February 22nd 2024

SYMPATICO Trial of Ibrutinib Plus Venetoclax Boosts PFS in MCL
SYMPATICO Trial of Ibrutinib Plus Venetoclax Boosts PFS in MCL

January 29th 2024

Liso-Cel Delivers Deep, Durable Responses in R/R MCL
Liso-Cel Delivers Deep, Durable Responses in R/R MCL

January 11th 2024

Video Series
Video Interviews

More News